Literature DB >> 14670317

Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins.

Andrew A Potter1, Sandra Klashinsky, Yuling Li, Elizabeth Frey, Hugh Townsend, Dragan Rogan, Galen Erickson, Susanne Hinkley, Terry Klopfenstein, Rodney A Moxley, David R Smith, B Brett Finlay.   

Abstract

Cattle are an important reservoir of Escherichia coli O157:H7 leading to contamination of food and water, and subsequent human disease. This pathogen colonizes its hosts by producing several proteins such as Tir and EspA that are secreted by a type III secretion system. These proteins play a role in colonization of the intestine, suggesting that they might be useful targets for the development of a vaccine to reduce levels of this organism in cattle. Vaccination of cattle with proteins secreted by E. coli O157:H7 significantly reduced the numbers of bacteria shed in feces, the numbers of animals that shed, and the duration of shedding in an experimental challenge model. Vaccination of cattle also significantly (P=0.04) reduced the prevalence of E. coli O157:H7 in a clinical trial conducted in a typical feedlot setting. This strategy suggests it is possible to vaccinate cattle to decrease the level of E. coli O157:H7 shedding for the purpose of reducing the risk of human disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14670317     DOI: 10.1016/j.vaccine.2003.08.007

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  63 in total

Review 1.  Probiotics. Some evidence of their effectiveness.

Authors:  Gregor Reid; Jo-Anne Hammond
Journal:  Can Fam Physician       Date:  2005-11       Impact factor: 3.275

2.  Proteomics-based expression library screening (PELS): a novel method for rapidly defining microbial immunoproteomes.

Authors:  Indira T Kudva; Bryan Krastins; Haiqing Sheng; Robert W Griffin; David A Sarracino; Phillip I Tarr; Carolyn J Hovde; Stephen B Calderwood; Manohar John
Journal:  Mol Cell Proteomics       Date:  2006-05-31       Impact factor: 5.911

3.  Impact of the direct application of therapeutic agents to the terminal recta of experimentally colonized calves on Escherichia coli O157:H7 shedding.

Authors:  Stuart W Naylor; Pablo Nart; Jill Sales; Allen Flockhart; David L Gally; J Christopher Low
Journal:  Appl Environ Microbiol       Date:  2007-01-12       Impact factor: 4.792

4.  Transcriptional regulators of the GAD acid stress island are carried by effector protein-encoding prophages and indirectly control type III secretion in enterohemorrhagic Escherichia coli O157:H7.

Authors:  Jai J Tree; Andrew J Roe; Allen Flockhart; Sean P McAteer; Xuefang Xu; Darren Shaw; Arvind Mahajan; Scott A Beatson; Angus Best; Sabrina Lotz; Martin J Woodward; Roberto La Ragione; Kenan C Murphy; John M Leong; David L Gally
Journal:  Mol Microbiol       Date:  2011-04-15       Impact factor: 3.501

5.  The Escherichia coli O157:H7 cattle immunoproteome includes outer membrane protein A (OmpA), a modulator of adherence to bovine rectoanal junction squamous epithelial (RSE) cells.

Authors:  Indira T Kudva; Bryan Krastins; Alfredo G Torres; Robert W Griffin; Haiqing Sheng; David A Sarracino; Carolyn J Hovde; Stephen B Calderwood; Manohar John
Journal:  Proteomics       Date:  2015-03-09       Impact factor: 3.984

6.  Strain-dependent cellular immune responses in cattle following Escherichia coli O157:H7 colonization.

Authors:  Alexander Corbishley; Nur Indah Ahmad; Kirsty Hughes; Michael R Hutchings; Sean P McAteer; Timothy K Connelley; Helen Brown; David L Gally; Tom N McNeilly
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

Review 7.  Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.

Authors:  Miguel O'Ryan; Roberto Vidal; Felipe del Canto; Juan Carlos Salazar; David Montero
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 8.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 9.  In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections.

Authors:  Robyn J Law; Lihi Gur-Arie; Ilan Rosenshine; B Brett Finlay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

10.  Case studies in Bayesian microbial risk assessments.

Authors:  Marc C Kennedy; Helen E Clough; Joanne Turner
Journal:  Environ Health       Date:  2009-12-21       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.